RE: Musella Foundation awards to IBAI27 Feb 2026 09:46
This grant is distinct from their general Brain Tumor Drug Copayment Assistance Program, which faced funding shortages and closures for much of 2025. Instead, these funds are part of a dedicated initiative to ensure the GaM treatment remains accessible while it moves through the regulatory process